MMP9 and coronary artery disorder: In a large prospective trial that included 1127 patients with documented CAD, the association between MMP-9 levels and the risk of fatal cardiovascular events showed a hazard ratio of 1.3 (95% CI (confidence interval), 1.1 to 1.6; P = 0.005) after adjustment for clinical and therapeutic confounders [16].